Does TOCILIZUMAB Cause Thrombophlebitis superficial? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Thrombophlebitis superficial have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.0% of all adverse event reports for TOCILIZUMAB.
8
Reports of Thrombophlebitis superficial with TOCILIZUMAB
0.0%
of all TOCILIZUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Thrombophlebitis superficial From TOCILIZUMAB?
Of the 8 reports, 3 (37.5%) required hospitalization.
Is Thrombophlebitis superficial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Thrombophlebitis superficial?
DROSPIRENONE\ETHINYL ESTRADIOL (160)
LENALIDOMIDE (121)
ETHINYL ESTRADIOL\ETONOGESTREL (93)
RIVAROXABAN (82)
YAZ (78)
YASMIN (65)
TESTOSTERONE (62)
HUMAN IMMUNOGLOBULIN G (43)
ADALIMUMAB (40)
CAPECITABINE (29)
Which TOCILIZUMAB Alternatives Have Lower Thrombophlebitis superficial Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE